MC38-hCLDN 18.2
品系基本信息
*使用本品系發(fā)表的文獻(xiàn)需注明: MC38-hCLDN 18.2 cell line (Cat. NO. NM-S13-TM10) was purchased from Shanghai Model Organisms Center, Inc..
驗(yàn)證數(shù)據(jù)
Figure 1. hCLAUDIN18.2 expression in MC38-hCLAUDIN18.2 cell line.
Figure 2. Tumor growth curve of MC38-hCLAUDIN18.2 allogeneic model (n=4).
Figure 3. Body weight curve of MC38-hCLAUDIN18.2 allogeneic model (n=4).
Figure 4. The expression of hCLAUDIN18.2 in humanized modified tumors by FACS.
Figure 5. PD-1 humanized mouse model implanted with MC38-hCLDN18.2 tumors to evaluate the in vivo antitumor efficacy of anti-hCLDN18.2 mAb alone and in combination with Keytruda.
你也可能感興趣
Tamoxifen誘導(dǎo)Cre-ERT2小鼠 使用指南
Cre-ERT2在無Tamoxifen誘導(dǎo)的情況下，在細(xì)胞質(zhì)內(nèi)處于無活性狀態(tài)；當(dāng)Tamoxifen誘導(dǎo)后，Tamoxifen的代謝產(chǎn)物4-OHT（雌激素類似物）與ERT結(jié)合，可使Cre-ERT2進(jìn)核發(fā)揮Cre重組酶活性。
查看
【小鼠大學(xué)問】基因工程小鼠的命名規(guī)則
常見的基因工程小鼠可以分為兩種命名方式，包括基因定點(diǎn)修飾的小鼠命名，比如：敲除、敲入、點(diǎn)突變等等，和隨機(jī)轉(zhuǎn)基因的小鼠命名。
查看
